Connect public, paid and private patent data with Google Patents Public Datasets

Occluding vasculature of a patient using embolic coil with improved platelet adhesion

Download PDF

Info

Publication number
US20050240216A1
US20050240216A1 US11168172 US16817205A US2005240216A1 US 20050240216 A1 US20050240216 A1 US 20050240216A1 US 11168172 US11168172 US 11168172 US 16817205 A US16817205 A US 16817205A US 2005240216 A1 US2005240216 A1 US 2005240216A1
Authority
US
Grant status
Application
Patent type
Prior art keywords
embolic
coils
coil
method
textured
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11168172
Inventor
Donald Jones
Vladimir Mitelberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Codman and Shurtleff Inc
Original Assignee
Jones Donald K
Vladimir Mitelberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • A61B17/12113Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/1214Coils or wires
    • A61B17/12145Coils or wires having a pre-set deployed three-dimensional shape
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/02Inorganic materials
    • A61L31/022Metals or alloys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0077Special surfaces of prostheses, e.g. for improving ingrowth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/36Materials or treatment for tissue regeneration for embolization or occlusion, e.g. vaso-occlusive compositions or devices

Abstract

A method as provided for occluding the vasculature of a patient. The method comprises the steps of providing a plurality of embolic coils having a textured surface. The embolic coils are introduced into the patient's vasculature. In this manner, the textured surface provides improved platelet adhesion compared to a non-textured surface, to promote clotting. In the illustrative embodiment, the embolic coil comprises a platinum-tungsten alloy wire and the texturing is performed by abrasion or sandblasting to provide substantially uniform roughness comprising pockets having diameters of about 0.125 microns to about fifty microns and depths of about 0.25 microns to about twenty microns.

Description

    FIELD OF THE INVENTION
  • [0001]
    The present invention concerns a novel method for occluding the vasculature of a patient and, more particularly, a method of treatment in which embolic coils are placed within the patient's vasculature.
  • BACKGROUND OF THE INVENTION
  • [0002]
    A known technique for treating a brain aneurysm of a patient includes the placement of embolic coils within the aneurysm. To this end, a catheter is introduced into the vessel leading to the aneurysm, and embolic coils are delivered to pack and fill the aneurysm. Ordinarily, a deployment system is used to deliver the coils, via the catheter, to the aneurysm, such as the deployment system disclosed in Hieshima U.S. Pat. No. 6,113,622, the disclosure of which is incorporated herein by reference.
  • [0003]
    The embolic coils act to reduce the blood flow inside of the aneurysm. Typically the embolic coils provide a mechanical blockage to the blood flow in the aneurysm. In this manner, the stagnation of blood that is obtained prevents the blood flow from rupturing the aneurysm. However, such stagnation forms a thrombus inside the aneurysm, that eventually can get resorbed.
  • [0004]
    We have discovered a method by which the desirable mechanical blockage of blood flow can be obtained with the addition of platelet adhesion to the embolic coils. This allows tissue to be able to grow, and the thrombus that forms, instead of being resorbed, has the ability to be organized into fibrous scar tissue. Such fibrous scar tissue achieves long term healing of the aneurysm in contrast to the use of embolic coils that can move around with the result that the formed thrombus may be resorbed
  • [0005]
    The method that we have discovered is useful for occluding the vasculature of a patient. In addition to embolizing an aneurysm, the method of the present invention may also be used for embolizing a vessel for vessel sacrifice; for reducing or blocking blood flow to an arterial-venous malformation or to a fistula; and for blocking blood flow to tumors.
  • [0006]
    It is, therefore, an object of the present invention to provide a novel method for occluding the vasculature of a patient using implanted embolic coils in which there is improved platelet adhesion to the coils.
  • [0007]
    A further object of the present invention to provide a novel method for treating an aneurysm of a patient using implanted embolic coils in which there is improved platelet adhesion to the coils.
  • [0008]
    Another object of the present invention is to provide a novel method for treating an aneurysm of a patient using embolic coils and enabling tissue formation to prevent the coils from moving around within the aneurysm.
  • [0009]
    A further object of the present invention is to provide a novel embolic coil that is simple in construction and easy to manufacture.
  • [0010]
    A still further object of the present invention is to provide a novel embolic coil which provides improved platelet adhesion.
  • [0011]
    Other objects and advantages of the present invention will become apparent as the description proceeds.
  • SUMMARY OF THE INVENTION
  • [0012]
    In accordance with the present invention, a method is provided for occluding the vasculature of a patient. The method comprises the steps of providing a plurality of embolic coils having a textured surface. The plurality of embolic coils having a textured surface are introduced into the patient's vasculature. In this manner, the textured surface provides improved platelet adhesion compared to a non-textured surface, to promote clotting.
  • [0013]
    In the illustrative embodiment, the surface of the embolic coils are textured by abrasion or sandblasting. The embolic coil comprises a platinum-tungsten alloy wire and in a specific example, the embolic coils have a substantially uniform roughness comprising pockets having diameters of between about 0.125 microns and about 50 microns and depths between about 0.25 microns to 20 microns.
  • [0014]
    A more detailed explanation of the invention is provided in the following description and claims, and is illustrated in the accompanying drawings.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0015]
    FIG. 1 is a view of an embolic coil constructed in accordance with the principles of the present invention.
  • [0016]
    FIG. 2 is a diagram of a patient's brain aneurysm having the coils of the present invention implanted therein.
  • [0017]
    FIG. 3 is a photomicrograph, enlarged 233×, showing a portion of an embolic coil with a smooth surface, prior to texturing.
  • [0018]
    FIG. 4 is a photomicrograph, enlarged 233×, showing a similar portion of an embolic coil as the FIG. 3 portion, but with texturing.
  • [0019]
    FIG. 5 is a photomicrograph, enlarged 3880×, showing a portion of an embolic coil with a smooth surface, prior to texturing.
  • [0020]
    FIG. 6 is a photomicrograph, enlarged 3880×, showing a similar portion of an embolic coil as the FIG. 5 portion, but with texturing
  • DETAILED DESCRIPTION OF THE ILLUSTRATIVE EMBODIMENT
  • [0021]
    Referring to the drawings, in FIG. 1 there is shown an embolic coil constructed in accordance with the principles of the present invention. Embolic coil 10 is formed by winding a platinum-tungsten alloy wire into a helical configuration. In the illustrative embodiment, the diameter of the wire is generally in the range of about 0.0015 to 0.008 inches. The outside diameter of the coil 10 is preferably in the range of about 0.006 to 0.055 inches. The embolic coil 10 shown in FIG. 1 may be straight or may take the form of various configurations, including the forms of a helix, a random shape configuration, or a coil within a coil configuration.
  • [0022]
    The details of construction of an example embolic coil, although no limitation is intended, is disclosed in Diaz et al. U.S. Pat. No. 6,063,100, issued May 16, 2000, the disclosure of which is incorporated herein by reference.
  • [0023]
    With the helical wound coil as illustrated in FIG, 1 the coil is provided with a seal plug 12 at its distal end and another seal plug 14 at its proximal end. Seal plugs 12 and 14 serve to prevent the flow of fluid through the lumen of the coil 10.
  • [0024]
    Although no limitation is intended, as a specific example coil 10 is formed of a platinum-tungsten alloy comprising 92% platinum and 8% tungsten. In accordance with the present invention, the outer surface of the coil is textured by abrasion or sandblasting. To this end, fifty-micron diameter alumina particles are used to texture the surface of the wire that is used to form the coils, prior to the formation of the helical coils. It has been found that the textured surface provides improved platelet adhesion thus promoting clotting and subsequent endothelialization.
  • [0025]
    Although no limitation is intended, as a specific example the texturization provides a uniform roughness comprising pockets having diameters of between about 0.125 microns and about 50 microns and depths of between about 0.25 microns and about 20 microns. The roughness is uniform throughout the coil except if the coil is used with a detachment system such as disclosed in Hieshima U.S. Pat. No. 6,113,622 or Diaz et al. U.S. Pat. No. 6,063,100, a proximal portion of the coil is not textured in order for it to have a proper seal with a gripper so that it can released easily.
  • [0026]
    FIG. 2 is a diagrammatic view of a patient's vessel 16 leading to an aneurysm 18 into which a number of embolic coils 10 have been introduced. The coils are introduced in a manner known in the art, by introducing a catheter into the vessel 16, then introducing a deployment device via the catheter to deliver the embolic coils, one by one, to the aneurysm 18.
  • [0027]
    SEM micrographs of the non-textured vs. textured coils are provided in FIGS. 3-6. Referring to FIG. 3, a portion of a non-textured coil is shown in a micrograph having an enlargement of 233×. FIG. 4 shows a similar coil with a 233× enlargement, but with texture that has been provided by sandblasting as disclosed above. FIG. 5 is a greatly enlarged micrograph, having an enlargement of 3380×, of the coil sample of FIG. 3 and FIG. 6 is a greatly enlarged micrograph having an enlargement of 3880×, of the coil sample of FIG. 5.
  • [0028]
    Testing was conducted using radiolabeled platelets to evaluate an ex vivo aneurysm model. In the model, aneurysms treated with textured coils were compared to aneurysms treated with non-textured coils. The textured coils showed an increased in the platelet deposition of about fifty percent over the non-texture coils.
  • [0029]
    It can be seen that by using embolic coils that have been textured, there is superior platelet adhesion which promotes clotting and subsequent endothelialization. A texturing technique has been disclosed that is simple and does not require expensive or elaborate equipment to modify the coils. In the illustrative embodiment the texturing technique does not require coating or ion implantation, thereby avoiding the importation of any new materials to the coil that would require new biocompatability testing.
  • [0030]
    Although an illustrative embodiment of the invention has been shown and described, it is to be understood that various modifications and substitutions may be made by those skilled in the art without departing from the novel spirit and scope of the present invention.

Claims (20)

1. A method for occluding the vasculature of a patient, comprising the steps of:
providing a plurality of embolic coils having a textured surface;
introducing said plurality of embolic coils into the patient's vasculature, whereby the textured surface provides improved platelet adhesion compared to a non-textured surface, to promote clotting.
2. A method as defined in claim 1, including the step of texturing the surface of an embolic coil by abrasion.
3. A method as defined in claim 1, including the step of texturing the surface of an embolic coil by sandblasting.
4. A method as defined in claim 1, in which said embolic coil comprises a platinum-tungsten alloy wire.
5. A method as defined in claim 1, in which said embolic coil includes a proximal portion and a distal portion; said proximal portion being relatively smooth and said distal portion being relatively textured.
6. A method as defined in claim 1, in which said embolic coil has substantially uniform roughness comprises pockets having diameters between about 0.125 microns and about 50 microns.
7. A method as defined in claim 6, in which said pockets have depths of between about 0.25 microns and about 20 microns.
8. A method as defined in claim 1, in which the embolic coils are used to embolize a vessel for vessel sacrifice.
9. A method as defined in claim 1, in which the embolic coils are used to reduce or block blood flow to an arterial-venous malformation or to a fistula.
10. A method as defined in claim 1, in which the embolic coils are used to block blood flow to tumor.
11. A method for treating an aneurysm of a patient, comprising the steps of:
providing a plurality of embolic coils having a textured surface;
introducing said plurality of embolic coils into the patient's aneurysm, whereby the textured surface provides improved platelet adhesion compared to a non-textured surface, to promote clotting.
12. A method as defined in claim including the step of texturing the surface of an embolic coil by abrasion.
13. A method as defined in claim 11, including the step of texturing the surface of an embolic coil by sandblasting.
14. A method as defined in claim 11, in which said embolic coil comprises a platinum-tungsten alloy wire.
15. A method as defined in claim 11, in which said embolic coil includes a proximal portion and a distal portion; said proximal portion being relatively smooth and said distal portion being relatively textured.
16. A method as defined in claim 11, in which said embolic coil has substantially uniform roughness comprises pockets having diameters between about 0.125 microns and about 50 microns.
17. A method as defined in claim 11, in which said pockets have depths of between about 0.25 microns and about 20 microns.
18. A method for occluding the vasculature of a patient, comprising the steps of:
providing a plurality of embolic coils formed of a platinum-tungsten alloy;
texturizing the surface of said embolic coils by abrasion or sandblasting;
introducing said plurality of textured embolic coils into the patient's vasculature, whereby the textured surface provides improved platelet adhesion compared to a non-textured surface, to promote clotting.
19. A method as defined in claim 18, in which said embolic coils have substantially uniform roughness comprising pockets having diameters of between about 0.125 microns and about 50 microns and depths of between about 0.25 microns and about 20 microns.
20. A embolic coil formed of a platinum alloy wire and having a textured surface which, when said embolic coil is implanted in a patient's vasculature, provides improved platelet adhesion compared to a non-textured surface, to promote clotting.
US11168172 2001-06-13 2005-06-28 Occluding vasculature of a patient using embolic coil with improved platelet adhesion Abandoned US20050240216A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US09880506 US6953468B2 (en) 2001-06-13 2001-06-13 Occluding vasculature of a patient using embolic coil with improved platelet adhesion
US11168172 US20050240216A1 (en) 2001-06-13 2005-06-28 Occluding vasculature of a patient using embolic coil with improved platelet adhesion

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11168172 US20050240216A1 (en) 2001-06-13 2005-06-28 Occluding vasculature of a patient using embolic coil with improved platelet adhesion

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09880506 Division US6953468B2 (en) 2001-06-13 2001-06-13 Occluding vasculature of a patient using embolic coil with improved platelet adhesion

Publications (1)

Publication Number Publication Date
US20050240216A1 true true US20050240216A1 (en) 2005-10-27

Family

ID=25376423

Family Applications (2)

Application Number Title Priority Date Filing Date
US09880506 Active 2022-05-10 US6953468B2 (en) 2001-06-13 2001-06-13 Occluding vasculature of a patient using embolic coil with improved platelet adhesion
US11168172 Abandoned US20050240216A1 (en) 2001-06-13 2005-06-28 Occluding vasculature of a patient using embolic coil with improved platelet adhesion

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09880506 Active 2022-05-10 US6953468B2 (en) 2001-06-13 2001-06-13 Occluding vasculature of a patient using embolic coil with improved platelet adhesion

Country Status (4)

Country Link
US (2) US6953468B2 (en)
JP (1) JP4236871B2 (en)
DE (2) DE60219995T2 (en)
EP (1) EP1266631B1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100036412A1 (en) * 2008-08-06 2010-02-11 Boston Scientific Scimed,Inc. Vaso-occlusive devices with textured surfaces
US8177809B2 (en) 2008-09-04 2012-05-15 Curaseal Inc. Inflatable device for enteric fistula treatment
US9131941B2 (en) 2011-06-17 2015-09-15 Curaseal Inc. Fistula treatment devices and methods
US9211116B2 (en) 2011-06-16 2015-12-15 Curaseal Inc. Fistula treatment devices and related methods

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7033374B2 (en) * 2000-09-26 2006-04-25 Microvention, Inc. Microcoil vaso-occlusive device with multi-axis secondary configuration
US6953468B2 (en) * 2001-06-13 2005-10-11 Cordis Neurovascular, Inc. Occluding vasculature of a patient using embolic coil with improved platelet adhesion
US8715312B2 (en) * 2001-07-20 2014-05-06 Microvention, Inc. Aneurysm treatment device and method of use
US7572288B2 (en) 2001-07-20 2009-08-11 Microvention, Inc. Aneurysm treatment device and method of use
US8252040B2 (en) 2001-07-20 2012-08-28 Microvention, Inc. Aneurysm treatment device and method of use
US20060292206A1 (en) 2001-11-26 2006-12-28 Kim Steven W Devices and methods for treatment of vascular aneurysms
US20030199887A1 (en) * 2002-04-23 2003-10-23 David Ferrera Filamentous embolization device and method of use
DE10233085B4 (en) 2002-07-19 2014-02-20 Dendron Gmbh Stent with guidewire
US7481821B2 (en) 2002-11-12 2009-01-27 Thomas J. Fogarty Embolization device and a method of using the same
US20040260382A1 (en) 2003-02-12 2004-12-23 Fogarty Thomas J. Intravascular implants and methods of using the same
US20050015110A1 (en) * 2003-07-18 2005-01-20 Fogarty Thomas J. Embolization device and a method of using the same
US20110054511A1 (en) * 2005-01-26 2011-03-03 Micrus Endovascular Corporation Adding microscopic porosity to the surface of a microcoil to be used for medical implantation
WO2006081407A1 (en) * 2005-01-26 2006-08-03 Micrus Corporation Implantable microcoil with microscopic porosity surface
US20080269774A1 (en) 2006-10-26 2008-10-30 Chestnut Medical Technologies, Inc. Intracorporeal Grasping Device
JP5734650B2 (en) * 2007-06-25 2015-06-17 マイクロベンション インコーポレイテッド The self-expanding prosthesis
US8940003B2 (en) 2008-02-22 2015-01-27 Covidien Lp Methods and apparatus for flow restoration
JP4312255B1 (en) 2008-12-22 2009-08-12 規方 田熊 Aneurysm embolization device, and its handling method
JP4499831B1 (en) 2010-01-22 2010-07-07 規方 田熊 Aneurysm embolization device
US9039749B2 (en) 2010-10-01 2015-05-26 Covidien Lp Methods and apparatuses for flow restoration and implanting members in the human body
EP3027124A2 (en) 2013-07-31 2016-06-08 Emba Medical Limited Methods and devices for endovascular embolization

Citations (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923460A (en) * 1989-01-23 1990-05-08 Aris Enterprises, Ltd. Spring element for hair-removal device
US5163958A (en) * 1989-02-02 1992-11-17 Cordis Corporation Carbon coated tubular endoprosthesis
US5261916A (en) * 1991-12-12 1993-11-16 Target Therapeutics Detachable pusher-vasoocclusive coil assembly with interlocking ball and keyway coupling
US5354295A (en) * 1990-03-13 1994-10-11 Target Therapeutics, Inc. In an endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5354259A (en) * 1993-01-25 1994-10-11 Minnesota Mining And Manufacturing Company Microfiber fillers for orthopedic casting tapes
US5382259A (en) * 1992-10-26 1995-01-17 Target Therapeutics, Inc. Vasoocclusion coil with attached tubular woven or braided fibrous covering
US5500013A (en) * 1991-10-04 1996-03-19 Scimed Life Systems, Inc. Biodegradable drug delivery vascular stent
US5551954A (en) * 1991-10-04 1996-09-03 Scimed Life Systems, Inc. Biodegradable drug delivery vascular stent
US5690671A (en) * 1994-12-13 1997-11-25 Micro Interventional Systems, Inc. Embolic elements and methods and apparatus for their delivery
US5911731A (en) * 1995-04-20 1999-06-15 Target Therapeutics, Inc. Anatomically shaped vasoocclusive devices
US5964797A (en) * 1996-08-30 1999-10-12 Target Therapeutics, Inc. Electrolytically deployable braided vaso-occlusion device
US5984956A (en) * 1997-10-06 1999-11-16 Heartstent Corporation Transmyocardial implant
US6024754A (en) * 1996-01-18 2000-02-15 Target Therapeutics Inc. Aneurysm closure method
US6033582A (en) * 1996-01-22 2000-03-07 Etex Corporation Surface modification of medical implants
US6063100A (en) * 1998-03-10 2000-05-16 Cordis Corporation Embolic coil deployment system with improved embolic coil
US6096052A (en) * 1998-07-08 2000-08-01 Ovion, Inc. Occluding device and method of use
US6113622A (en) * 1998-03-10 2000-09-05 Cordis Corporation Embolic coil hydraulic deployment system
US6231590B1 (en) * 1998-11-10 2001-05-15 Scimed Life Systems, Inc. Bioactive coating for vaso-occlusive devices
US6280457B1 (en) * 1999-06-04 2001-08-28 Scimed Life Systems, Inc. Polymer covered vaso-occlusive devices and methods of producing such devices
US6299627B1 (en) * 1998-06-18 2001-10-09 Target Therapeutics, Inc. Water-soluble coating for bioactive vasoocclusive devices
US20010044629A1 (en) * 1998-07-27 2001-11-22 Schneider (Usa), Inc. Neuroaneurysm occlusion and delivery device and method of using same
US6530934B1 (en) * 2000-06-06 2003-03-11 Sarcos Lc Embolic device composed of a linear sequence of miniature beads
US6660020B2 (en) * 1996-12-30 2003-12-09 Target Therapeutics, Inc. Vaso-occlusive coil with conical end
US6953468B2 (en) * 2001-06-13 2005-10-11 Cordis Neurovascular, Inc. Occluding vasculature of a patient using embolic coil with improved platelet adhesion

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2696636A1 (en) 1992-10-13 1994-04-15 Balt Sa Temporary wire-based blocking system for blood vessel etc. - uses coiled tubular tungsten@ wire to promote localised clotting, with hollow catheter for introduction of wire to required location
GB9614950D0 (en) 1996-07-16 1996-09-04 Anson Medical Ltd A ductus stent and delivery catheter

Patent Citations (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923460A (en) * 1989-01-23 1990-05-08 Aris Enterprises, Ltd. Spring element for hair-removal device
US5163958A (en) * 1989-02-02 1992-11-17 Cordis Corporation Carbon coated tubular endoprosthesis
US5354295A (en) * 1990-03-13 1994-10-11 Target Therapeutics, Inc. In an endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5500013A (en) * 1991-10-04 1996-03-19 Scimed Life Systems, Inc. Biodegradable drug delivery vascular stent
US5551954A (en) * 1991-10-04 1996-09-03 Scimed Life Systems, Inc. Biodegradable drug delivery vascular stent
US5261916A (en) * 1991-12-12 1993-11-16 Target Therapeutics Detachable pusher-vasoocclusive coil assembly with interlocking ball and keyway coupling
US5382259A (en) * 1992-10-26 1995-01-17 Target Therapeutics, Inc. Vasoocclusion coil with attached tubular woven or braided fibrous covering
US5354259A (en) * 1993-01-25 1994-10-11 Minnesota Mining And Manufacturing Company Microfiber fillers for orthopedic casting tapes
US5690671A (en) * 1994-12-13 1997-11-25 Micro Interventional Systems, Inc. Embolic elements and methods and apparatus for their delivery
US6165198A (en) * 1994-12-13 2000-12-26 Medtronic, Inc. Embolic elements and methods and apparatus for their delivery
US5911731A (en) * 1995-04-20 1999-06-15 Target Therapeutics, Inc. Anatomically shaped vasoocclusive devices
US6024754A (en) * 1996-01-18 2000-02-15 Target Therapeutics Inc. Aneurysm closure method
US6033582A (en) * 1996-01-22 2000-03-07 Etex Corporation Surface modification of medical implants
US5964797A (en) * 1996-08-30 1999-10-12 Target Therapeutics, Inc. Electrolytically deployable braided vaso-occlusion device
US6660020B2 (en) * 1996-12-30 2003-12-09 Target Therapeutics, Inc. Vaso-occlusive coil with conical end
US5984956A (en) * 1997-10-06 1999-11-16 Heartstent Corporation Transmyocardial implant
US6063100A (en) * 1998-03-10 2000-05-16 Cordis Corporation Embolic coil deployment system with improved embolic coil
US6113622A (en) * 1998-03-10 2000-09-05 Cordis Corporation Embolic coil hydraulic deployment system
US6299627B1 (en) * 1998-06-18 2001-10-09 Target Therapeutics, Inc. Water-soluble coating for bioactive vasoocclusive devices
US6096052A (en) * 1998-07-08 2000-08-01 Ovion, Inc. Occluding device and method of use
US20010044629A1 (en) * 1998-07-27 2001-11-22 Schneider (Usa), Inc. Neuroaneurysm occlusion and delivery device and method of using same
US6231590B1 (en) * 1998-11-10 2001-05-15 Scimed Life Systems, Inc. Bioactive coating for vaso-occlusive devices
US6280457B1 (en) * 1999-06-04 2001-08-28 Scimed Life Systems, Inc. Polymer covered vaso-occlusive devices and methods of producing such devices
US6530934B1 (en) * 2000-06-06 2003-03-11 Sarcos Lc Embolic device composed of a linear sequence of miniature beads
US6953468B2 (en) * 2001-06-13 2005-10-11 Cordis Neurovascular, Inc. Occluding vasculature of a patient using embolic coil with improved platelet adhesion

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100036412A1 (en) * 2008-08-06 2010-02-11 Boston Scientific Scimed,Inc. Vaso-occlusive devices with textured surfaces
US9622751B2 (en) * 2008-08-06 2017-04-18 Boston Scientific Scimed, Inc. Vaso-occlusive devices with textured surfaces
US8206416B2 (en) 2008-09-04 2012-06-26 Curaseal Inc. Inflatable device for enteric fistula treatment
US8221451B2 (en) 2008-09-04 2012-07-17 Curaseal Inc. Inflatable device for enteric fistula treatment
US8377094B2 (en) 2008-09-04 2013-02-19 Curaseal Inc. Enteric fistula treatment devices
US8177809B2 (en) 2008-09-04 2012-05-15 Curaseal Inc. Inflatable device for enteric fistula treatment
US9211116B2 (en) 2011-06-16 2015-12-15 Curaseal Inc. Fistula treatment devices and related methods
US9131941B2 (en) 2011-06-17 2015-09-15 Curaseal Inc. Fistula treatment devices and methods

Also Published As

Publication number Publication date Type
EP1266631A1 (en) 2002-12-18 application
DE60219995T2 (en) 2008-01-17 grant
JP2003070794A (en) 2003-03-11 application
DE60219995D1 (en) 2007-06-21 grant
JP4236871B2 (en) 2009-03-11 grant
EP1266631B1 (en) 2007-05-09 grant
US6953468B2 (en) 2005-10-11 grant
US20030004531A1 (en) 2003-01-02 application

Similar Documents

Publication Publication Date Title
US5645558A (en) Anatomically shaped vasoocclusive device and method of making the same
US5797953A (en) Helical embolization coil
US5382259A (en) Vasoocclusion coil with attached tubular woven or braided fibrous covering
US6036720A (en) Sheet metal aneurysm neck bridge
US5549624A (en) Fibered vasooclusion coils
US6136015A (en) Vasoocclusive coil
US6168592B1 (en) Aneurysm closure device assembly
US6635069B1 (en) Non-overlapping spherical three-dimensional coil
US6511468B1 (en) Device and method for controlling injection of liquid embolic composition
US6096034A (en) Aneurysm closure device assembly
US6497671B2 (en) Coated superelastic stent
US6171326B1 (en) Three dimensional, low friction vasoocclusive coil, and method of manufacture
US20060241690A1 (en) Multi-layer braided structures for occluding vascular defects and for occluding fluid flow through portions of the vasculature of the body
US20120259404A1 (en) Stent
US6165194A (en) Intravascular flow modifier and reinforcement device
US5725546A (en) Detachable microcoil delivery catheter
US6001092A (en) Complex coils having fibered centers
US20040111112A1 (en) Method and apparatus for retaining embolic material
US5649949A (en) Variable cross-section conical vasoocclusive coils
US6187024B1 (en) Bioactive coating for vaso-occlusive devices
US5624461A (en) Three dimensional in-filling vaso-occlusive coils
US5935145A (en) Vaso-occlusive device with attached polymeric materials
US6860893B2 (en) Stable coil designs
US6425914B1 (en) Fast-detaching electrically insulated implant
US7896899B2 (en) Metallic coils enlaced with biological or biodegradable or synthetic polymers or fibers for embolization of a body cavity

Legal Events

Date Code Title Description
AS Assignment

Owner name: CODMAN & SHURTLEFF, INC., MASSACHUSETTS

Free format text: MERGER;ASSIGNOR:CORDIS NEUROVASCULAR, INC.;REEL/FRAME:023032/0233

Effective date: 20081216

Owner name: CODMAN & SHURTLEFF, INC.,MASSACHUSETTS

Free format text: MERGER;ASSIGNOR:CORDIS NEUROVASCULAR, INC.;REEL/FRAME:023032/0233

Effective date: 20081216